AI THERAPEUTICS

AI Therapeutics was founded in 2013 with a mission to advance the clinical development of new therapies to treat Lymphangioleiomyomatosis (LAM) and other diseases. Working with a dedicated team of scientific, clinical, and drug development experts, AI Therapeutics expects to use its disease-specific focus and technological approach to identify and advance drugs that will provide significant therapeutic benefits for LAM patients. AI Therapeutics develops drugs for rare diseases and cancer. LAM ... takes advantage of the inflection point in biological understanding and computer science, leveraging big data from NextGen sequencing, genome editing, chemical genomics, and combinational drug screening, to develop precision therapeutics and companion diagnostics. LAM has advanced two drugs into the clinic: LAM-001 for lymphangioleiomyomatosis, and LAM-002 for B-cell non-Hodgkin lymphoma.

#People #Financial #Event #Website #More

AI THERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Artificial Intelligence Biotechnology Genetics Medical Therapeutics

Founded:

2013-01-01

Address:

Guilford, Connecticut, United States

Country:

United States

Website Url:

http://www.ai-therapeutics.com

Total Employee:

101+

Status:

Active

Contact:

(203)458-7100

Email Addresses:

[email protected]

Total Funding:

98 M USD

Technology used in webpage:

Amazon GoDaddy DNS Facebook Sharer Pinterest GoDaddy AWS Global Accelerator GoDaddy Email Amazon Frankfurt Region Reddit

Current Advisors List

robert-spiegel_image

Robert Spiegel Member of the Scientific Advisory Board @ AI Therapeutics
Advisor

jonathan-m-rothberg_image

Jonathan M. Rothberg Member of the Board of Directors @ AI Therapeutics
Board_member

joel-dudley_image

Joel Dudley Scientific Advisor @ AI Therapeutics
Advisor
2015-01-01

george-rehm_image

George Rehm Member of the Board of Directors @ AI Therapeutics
Board_member

brendan-manning_image

Brendan Manning Member of the Scientific Advisory Board @ AI Therapeutics
Advisor

tian-xu_image

Tian Xu Member of the Scientific Advisory Board @ AI Therapeutics
Advisor

joel-bader_image

Joel Bader Member of the Scientific Advisory Board @ AI Therapeutics
Advisor

joel-dudley_image

Joel Dudley Scientific Advisor @ AI Therapeutics
Advisor
2015-01-01

Current Employees Featured

joan-edwards_image

Joan Edwards
Joan Edwards Chief Quality Assurance Officer @ AI Therapeutics
Chief Quality Assurance Officer

keith-fandrick_image

Keith Fandrick
Keith Fandrick Chief Development Officer @ AI Therapeutics
Chief Development Officer
2017-05-01

peter-young_image

Peter Young
Peter Young Chief Scientific Officer @ AI Therapeutics
Chief Scientific Officer
2021-01-01

tian-xu_image

Tian Xu
Tian Xu Co-Founder @ AI Therapeutics
Co-Founder

scott-kozak_image

Scott Kozak
Scott Kozak Chief Business Development Officer @ AI Therapeutics
Chief Business Development Officer
2020-12-01

brigette-roberts_image

Brigette Roberts
Brigette Roberts CEO @ AI Therapeutics
CEO
2021-12-01

Founder

tian-xu_image

Tian Xu

Investors List

bioventure_image

BioVenture

BioVenture investment in Series C - AI Therapeutics

4catalyzer_image

4Catalyzer

4Catalyzer investment in Seed Round - AI Therapeutics

Key Employee Changes

Date	New article
2022-02-16	AI Therapeutics Appoints Brigette Roberts, M.D., as Chief Executive Officer

Official Site Inspections

http://www.ai-therapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "AI Therapeutics" on Search Engine